Association of Metabolic Syndrome with the Adiponectin to Homeostasis Model Assessment of Insulin Resistance Ratio
Table 4
Odds ratios (95% CI) and ROC analysis for the association between each component of MetS and markers.
Adiponectin (Q4 versus Q1)
HOMA-IR (Q4 versus Q1)
A/H ratio (Q4 versus Q1)
OR (95% CI)
AUC (SE)
OR (95% CI)
AUC (SE)
OR (95% CI)
AUC (SE)
Abdominal obesity
0.37 (0.27–0.51)
0.58 (0.01)
2.74 (2.01–3.72)
0.61 (0.01)
0.20 (0.13–0.31)
0.63 (0.01)
High triglycerides
0.42 (0.28–0.65)
0.64 (0.02)
4.35 (2.82–6.71)
0.67 (0.02)
0.20 (0.13–0.31)
0.69 (0.02)
High blood pressure
0.33 (0.24–0.46)
0.61 (0.01)
1.55 (1.14–2.10)
0.55 (0.01)
0.44 (0.33–0.59)
0.61 (0.01)
Low HDL
0.71 (0.51–0.99)
0.51 (0.02)
1.74 (1.25–2.42)
0.57 (0.02)
0.50 (0.36–0.69)
0.55 (0.02)
Abnormal glucose
0.42 (0.28–0.63)
0.63 (0.02)
10.08 (6.32–16.06)
0.75 (0.02)
0.14 (0.09–0.23)
0.73 (0.02)
CI, confidence interval; AUC, area under the curve; SE, standard error; A/H ratio, adiponectin to homeostasis assessment-insulin resistance; MetS, metabolic syndrome; Q4, highest quartile; Q1, lowest quartile. Adjusted for sex, age, smoking status, and LDL cholesterol.
